Stocktoria
Septerna, Inc. SEPN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-10-25
Chart by TradingView
4/9
Piotroski F — financial health
3.75
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $46.0M | $1.1M | $151,000 |
| Operating income | -$68.3M | -$80.8M | $2.1M |
| Net income | -$48.9M | -$71.8M | $4.2M |
| Operating cash flow | $110.2M | -$67.5M | -$38.7M |
| Free cash flow | $109.7M | -$69.6M | -$41.6M |
| Total assets | $596.2M | $456.6M | $130.9M |
| Total liabilities | $214.3M | $36.5M | $20.0M |
| Shareholders' equity | $381.9M | $420.0M | -$38.4M |
| Ratios | |||
| Operating margin | -148.6% | -7518.4% | 1374.2% |
| Net margin | -106.4% | -6678.9% | 2768.2% |
| FCF margin | 238.7% | -6471.9% | -27550.3% |
| Return on assets | -8.2% | -15.7% | 3.2% |
| Return on equity | -12.8% | -17.1% | -10.9% |
| Current ratio | 4.73 | 27.77 | 16.30 |
| Revenue growth | 4174.5% | 611.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 37,700 | $905,931 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.75 (safe)
- Working capital / assets 0.544
- Retained earnings / assets -0.281
- EBIT / assets -0.115
- Equity / liabilities 1.783
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001984086 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.